Rani Therapeutics develops the RaniPill capsule, an oral delivery technology for drugs and biologics that are now often given by injection. It last closed at $0.51 on Nov 20, down 11.97% on the day. The next earnings report for RANI is expected around Thu, Mar 25, 2027, after the close. For the quarter ended Sep 2026, RANI reported EPS of -$0.04 on revenue of $1.7M. Over its last 8 reports the stock moved an average of 8.4% the session after earnings. Over the last 12 months RANI insiders bought $50K of stock on the open market and sold $301, according to SEC Form 4 filings.
AI Auto Pilots
Is RANI in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RANI.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RANIStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RANI · as of the Nov 20 close · updated each morning
Downtrend
The stock is 11% below its 20 day and 33% below its 50 day average. It is 72% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 39). The nearest support is the swing low (Nov 5) at $0.51, and the nearest resistance the Pivot at $0.53.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 10.4%/day
Key levels
$1.8252 week high+256.9%
$0.88200 day average+72.5%
$0.74100 day average+45.1%
$0.6850 day average+33.3%
$0.58Swing high (Nov 11)+13.7%
$0.5720 day average+11.8%
$0.56Pivot R1+9.8%
$0.53Pivot+3.9%
$0.51Swing low (Nov 5)+0.0%
$0.51Last close
$0.5052 week low−2.0%
$0.49Pivot S1−3.9%
Indicators
RSI (14)
39.22
Weak, oversold below 30
Neutral
MACD
-0.03
Above its signal line
Bullish
Stochastic
52.5
Middle of its range
Neutral
ADX (14)
35.7
Trending down
Williams %R
-94.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-98.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−6.5%
Change over 10 sessions
Bearish
ATR (14)
$0.05
Typical daily range, 10.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 25.1%/day
Key levels
$1.8252 week high+256.9%
$0.88200 day average+72.5%
$0.74100 day average+45.1%
$0.6850 day average+33.3%
$0.58Swing high (Nov 11)+13.7%
$0.5720 day average+11.8%
$0.56Pivot R1+9.8%
$0.53Pivot+3.9%
$0.51Swing low (Nov 5)+0.0%
$0.51Last close
$0.5052 week low−2.0%
$0.49Pivot S1−3.9%
Indicators
RSI (14)
31.89
Weak, oversold below 30
Neutral
MACD
-0.10
Below its signal line
Bearish
Stochastic
5.5
Near the bottom of its range
Oversold
ADX (14)
14.8
No clear trend
Williams %R
-98.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-127.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−39.3%
Change over 10 sessions
Bearish
ATR (14)
$0.13
Typical daily range, 25.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for RANI
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RANI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow RANI usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RANIHow many large options trades hit RANI, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RANI in the last 90 days.
From SEC Form 4 filings by RANI's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RANI is in one of them and how their past RANI trades turned out.
Rani Therapeutics is a biotherapeutics company based in San Jose, California. It is developing the RaniPill capsule, a delivery technology designed to let drugs and biologics such as antibodies and peptides be taken orally instead of by injection. The company is advancing its own oral drug candidates and is seeking partnerships with biopharmaceutical companies to use its technology. Its intended customers include patients, physicians, and healthcare systems, and it has no approved products for sale yet.